MA54161A - Compositions comprenant des souches bactériennes parabacteroides pour le traitement du cancer - Google Patents

Compositions comprenant des souches bactériennes parabacteroides pour le traitement du cancer

Info

Publication number
MA54161A
MA54161A MA054161A MA54161A MA54161A MA 54161 A MA54161 A MA 54161A MA 054161 A MA054161 A MA 054161A MA 54161 A MA54161 A MA 54161A MA 54161 A MA54161 A MA 54161A
Authority
MA
Morocco
Prior art keywords
parabacteroid
cancer
compositions
treatment
bacterial strains
Prior art date
Application number
MA054161A
Other languages
English (en)
Inventor
Suaad Ahmed
Anna Ettorre
Parthena Fotiadou
Imke Elisabeth MULDER
Original Assignee
4D Pharma Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2019/080131 external-priority patent/WO2020089488A1/fr
Priority claimed from GBGB1916001.9A external-priority patent/GB201916001D0/en
Application filed by 4D Pharma Res Ltd filed Critical 4D Pharma Res Ltd
Publication of MA54161A publication Critical patent/MA54161A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MA054161A 2018-12-12 2019-12-12 Compositions comprenant des souches bactériennes parabacteroides pour le traitement du cancer MA54161A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18212087 2018-12-12
PCT/EP2019/080131 WO2020089488A1 (fr) 2018-11-02 2019-11-04 Compositions comprenant des souches bactériennes
GBGB1916001.9A GB201916001D0 (en) 2019-11-04 2019-11-04 Compositions comprising bacterial strains

Publications (1)

Publication Number Publication Date
MA54161A true MA54161A (fr) 2022-03-23

Family

ID=71075994

Family Applications (1)

Application Number Title Priority Date Filing Date
MA054161A MA54161A (fr) 2018-12-12 2019-12-12 Compositions comprenant des souches bactériennes parabacteroides pour le traitement du cancer

Country Status (15)

Country Link
US (1) US11446336B2 (fr)
EP (1) EP3876964A1 (fr)
JP (1) JP2022513208A (fr)
KR (1) KR20210102311A (fr)
CN (1) CN113207282A (fr)
AU (1) AU2019396657A1 (fr)
BR (1) BR112021010917A2 (fr)
CA (1) CA3122347A1 (fr)
EA (1) EA202191631A1 (fr)
IL (1) IL283851A (fr)
MA (1) MA54161A (fr)
MX (1) MX2021006863A (fr)
SG (1) SG11202106258YA (fr)
TW (1) TW202038978A (fr)
WO (1) WO2020120717A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020089488A1 (fr) * 2018-11-02 2020-05-07 4D Pharma Research Limited Compositions comprenant des souches bactériennes
CN113559275B (zh) * 2021-09-24 2021-12-24 广东粤港澳大湾区国家纳米科技创新研究院 一种一锅法制备高分子/康普瑞汀a4/blz945纳米键合药的方法
CN114588182B (zh) * 2021-12-28 2023-09-01 南京医科大学 植物乳杆菌l168辅助索拉非尼治疗肝癌的用途
CN120041316A (zh) * 2023-11-27 2025-05-27 慕恩（广州）生物科技有限公司 副拟杆菌属菌株、培养物、菌剂及其应用
CN120060478B (zh) * 2023-11-30 2026-03-31 华中农业大学 一种约氏副拟杆菌在卵巢衰老中的应用
CN118406582B (zh) * 2024-03-08 2025-12-16 中国医学科学院医学实验动物研究所 一种可抑制致病菌和抗肿瘤的狄氏副拟杆菌Parabacteroides distasonis及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
GB0127916D0 (en) 2001-11-21 2002-01-16 Rowett Res Inst Method
GB0526033D0 (en) 2005-12-21 2006-02-01 Bioeos Ltd Method
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
WO2016149449A1 (fr) 2015-03-18 2016-09-22 Tufts University Compositions et méthodes pour le traitement du cancer colorectal
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
EP3429604A1 (fr) * 2016-03-14 2019-01-23 Holobiome, Inc. Modulation du microbiome intestinal pour traiter les troubles mentaux ou les maladies du système nerveux central
WO2018094190A2 (fr) 2016-11-18 2018-05-24 Sanford Burnham Prebys Medical Discovery Institute Microbiote intestinal et traitement du cancer
US20190314427A1 (en) * 2016-12-16 2019-10-17 Evelo Biosciences, Inc. Methods of treating cancer using parabacteroides
WO2018112365A2 (fr) 2016-12-16 2018-06-21 Evelo Biosciences, Inc. Procédés de traitement du cancer colorectal et d'un mélanome en utilisant parabacteroides goldsteinii
RU2761873C2 (ru) 2016-12-23 2021-12-13 Кэйо Юниверсити Композиции и способы для индукции cd8+ t-клеток
TW201906620A (zh) 2017-07-05 2019-02-16 美商艾弗洛生物科技股份有限公司 使用動物雙岐桿菌乳亞種 (bifidobacterium animalis ssp. lactis) 治療癌症之組合物及方法

Also Published As

Publication number Publication date
EA202191631A1 (ru) 2021-09-03
CA3122347A1 (fr) 2020-06-18
MX2021006863A (es) 2021-09-14
SG11202106258YA (en) 2021-07-29
CN113207282A (zh) 2021-08-03
AU2019396657A1 (en) 2021-07-08
BR112021010917A2 (pt) 2021-08-31
JP2022513208A (ja) 2022-02-07
KR20210102311A (ko) 2021-08-19
WO2020120717A1 (fr) 2020-06-18
US20210283194A1 (en) 2021-09-16
IL283851A (en) 2021-07-29
EP3876964A1 (fr) 2021-09-15
US11446336B2 (en) 2022-09-20
TW202038978A (zh) 2020-11-01

Similar Documents

Publication Publication Date Title
FR25C1001I2 (fr) Compositions d'anticorps pour le traitement de tumeurs
MA41013A (fr) Compositions comprenant des souches bactériennes
MA54161A (fr) Compositions comprenant des souches bactériennes parabacteroides pour le traitement du cancer
MA44083A (fr) Composés de biarylmonobactame pour le traitement d'infections bactériennes
EP3431105A4 (fr) Composition médicinale pour le traitement du cancer
MA41060B1 (fr) Compositions comprenant des souches bactériennes
MA55434B1 (fr) Compositions comprenant des souches bactériennes
MA42471B1 (fr) Compositions comprenant des souches bactériennes
MA41010B1 (fr) Compositions comprenant des souches bactériennes
EP3400010A4 (fr) Combinaisons anti-her2 pour le traitement des tumeurs
EP3380200A4 (fr) Compositions pour le traitement des cheveux
EP3380063A4 (fr) Compositions pour le traitement des cheveux
EP3641746A4 (fr) Méthodes et compositions pour le traitement d'une infection microbienne
EP3541379A4 (fr) Compositions pour le traitement de l'hypertension
EP3773221A4 (fr) Traitement pour l'hydrocéphalie
EP3793544A4 (fr) Compositions bifonctionnelles pour le traitement du cancer
FR24C1053I2 (fr) Utilisation du delgocitinib pour le traitement de l'eczéma des mains chronique
EP3386593A4 (fr) Composition immunomodulatrice pour le traitement
MA45973A (fr) Combinaisons d'inhibiteurs de btk pour le traitement du myélome multiple
EP3638270A4 (fr) Compositions et méthodes pour l'amélioration d'un traitement par hyperthermie
PL3618826T3 (pl) Kompozycje do leczenia zakażeń patogenami
MA53155A (fr) Compositions comprenant des souches bactériennes
EP3373922A4 (fr) Compositions et méthodes pour le traitement de l'homocystinurie
EP3638287A4 (fr) Méthodes et compositions pour le traitement d'une inflammation microbienne
MA53860A (fr) Compositions comprenant des souches bactériennes